Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20150630022991N9
IRCT20150630022991N9CompletedPhase 3

Comparison of the Effectiveness of Sertraline and Fluoxetin in Diabetic Patients with Depression

Babol University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
40
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • •Age 18 years and above
  • •The presence of depressive symptoms in a clinical psychiatric interview
  • •The confirmation of diabetes type 2 diagnosed by an endocrinologist
  • •To provide the informed consent form

Exclusion Criteria

  • •Pregnancy or lactation
  • •Probability to migrate from the city in duration time of the study
  • •Comorbidity of uncontrolled cardiovascular or ophthalmic diseases

Investigators

Similar Trials

Recruiting
Phase 3
Comparison of the effectiveness of sertraline and Nortriptyline on anxiety and gastrointestinal symptoms in patients with irritable bowel syndromeIrritable bowel syndrome
IRCT20190618043934N13Birjand University of Medical Sciences192
Not yet recruiting
Phase 2
Comparison of the effect of sertraline and midodrine in improving blood pressure during hemodialysisHypotension of hemodialysis.Hypotension of hemodialysisI95.3
IRCT20100102002954N29Shahroud University of Medical Sciences82
Recruiting
Not Applicable
Comparison of therapeutic effect of sertraline and supportive psychotherapy in comparison with placebo in coronary heart disease patients with mild to moderate depressioCondition 1: Depression. Condition 2: Mild Depression. Condition 3: Moderate depression.F32 Depressive episode In typical mild, moderate, or severe depressive episodes, the patient suffers from lowering of mood, reduction of energy, and decrease in activity. Capacity for enjoyment, interest, and concentration is reduced, and marked tireF32.0 Mild depressive episode Two or three of the above symptoms are usually present. The patient is usually distressed by these but will probably be able to continue with most activities.F32.1 Moderate depressive episode Four or more of the above symptoms are usually present and the patient is likely to have great difficulty in continuing with ordinary activities.
IRCT20171105037241N2Zahedan University of Medical Sciences90
Recruiting
Phase 2
Evaluation of effectiveness of Sertraline and supportive psychotherapy on anxiety and depression level
IRCT20180425039418N4Zahedan University of Medical Sciences60
Recruiting
Phase 4
efficacy of sertraline, escitalopram in treatment of depression in patients undergoing chronic hemodialysis
IRCT20210424051066N1Shahid Beheshti University of Medical Sciences132